The need for effective contrast agents to enhance the performance of MR imaging.
Grant
D
D
Refsum
H
H
Rummeny
E
E
Marchal
G
G
D000818:Animals; D003287:Contrast Media / Q000009:adverse effects / Q000493:pharmacokinetics; D004492:Edetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008345:Manganese / Q000009:adverse effects / Q000493:pharmacokinetics; D011732:Pyridoxal Phosphate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D003287:Contrast Media; D008345:Manganese; D011732:Pyridoxal Phosphate; D004492:Edetic Acid; C060076:N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid